Back to search

Article

Genetically proxied inhibition of interleukin-6 signaling: opposing associations with susceptibility to COVID-19 and pneumonia

2020-09-18

Abstract excerpt

<h4>ABSTRACT</h4> The inflammatory cytokine interleukin-6 (IL-6) is pivotal for orchestrating the immune response. Inhibitors of IL-6 signaling are being investigated as treatments for severe coronavirus disease 2019 (COVID-19). We conducted a Mendelian randomization study investigating the effect of IL-6 signaling on susceptibility to COVID-19 and pneumonia. Our results showed that genetically proxied inhibition...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f173c89-80db-5c60-af49-9434c2c7aab2
DOI
10.1101/2020.09.15.20165886
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetically proxied inhibition of interleukin-6 signaling: opposing associations with susceptibility to COVID-19 and pneumoniaDOI 10.1101/2020.09.15.20165886
Select a neighboring publication to make it the new centre.